PCMA Statement on New Class-Action Lawsuit Against Drug Companies

Tuesday, January 31, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

WASHINGTON, Jan. 30, 2017 /PRNewswire-USNewswire/ -- The Pharmaceutical Care Management Association (PCMA) issued the following

statement on today's new class-action lawsuit against three makers of insulin drug products:

"While we're still reviewing the details of the lawsuit – in which pharmacy benefit managers (PBMs) are not named as defendants – it inexplicably attacks

prescription drug rebates, long used to reduce costs in public programs like Medicaid and in the commercial market. 

While none of America's largest, most sophisticated health purchasers – including Fortune 500 companies, health plans, and Medicare Part D plans – are required to use the services of a PBM, almost all choose to because they reduce costs and improve the quality of benefits."

PCMA is the national association representing America's pharmacy benefit managers (PBMs). PBMs administer prescription drug plans for more than 266 million Americans who have health insurance from a variety of sponsors including: commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, managed Medicaid plans, and others.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pcma-statement-on-new-class-action-lawsuit-against-drug-companies-300399022.html

SOURCE Pharmaceutical Care Management Association



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store